<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Eichin D</submitter><funding>Academy of Finland (Suomen Akatemia)</funding><funding>Syöpäsäätiö (Cancer Foundation Finland)</funding><pagination>10056</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12623973</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Cancer metastasis to sentinel lymph nodes (LNs) is often the first marker of potential disease progression. Although it is recognized that tumor-induced lymphangiogenesis facilitates metastasis into LNs in murine models, tumor-induced alterations in human lymphatic vessels remain obscure. Here we use single-cell RNA sequencing and high-resolution spatial transcriptomics to profile lymphatic endothelial cell (LEC) subsets in paired metastatic and non-metastatic LNs obtained from female patients with treatment-naïve breast cancer. Tumor metastasis decreases immunoregulatory LEC subsets, such as PD-L1&lt;sup>+&lt;/sup> subcapsular sinus LECs, while inducing an increase in capillary-like CD200&lt;sup>+&lt;/sup> HEY1&lt;sup>+&lt;/sup> LECs. Matrix Gla protein (MGP) is the most upregulated gene in metastatic LN L</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Breast cancer remodels lymphatics in sentinel lymph nodes.</pubmed_title><pmcid>PMC12623973</pmcid><funding_grant_id>336269</funding_grant_id><funding_grant_id>A2649</funding_grant_id><funding_grant_id>A2473</funding_grant_id><pubmed_authors>Hollmen M</pubmed_authors><pubmed_authors>Lehotina D</pubmed_authors><pubmed_authors>Lonnberg T</pubmed_authors><pubmed_authors>Eichin D</pubmed_authors><pubmed_authors>Piipponen M</pubmed_authors><pubmed_authors>Aittokallio T</pubmed_authors><pubmed_authors>Uenaka M</pubmed_authors><pubmed_authors>Leppanen M</pubmed_authors><pubmed_authors>Elima K</pubmed_authors><pubmed_authors>Bostrom P</pubmed_authors><pubmed_authors>Takeda A</pubmed_authors><pubmed_authors>Kauko A</pubmed_authors><pubmed_authors>Koskivuo I</pubmed_authors><pubmed_authors>Jalkanen S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Breast cancer remodels lymphatics in sentinel lymph nodes.</name><description>Cancer metastasis to sentinel lymph nodes (LNs) is often the first marker of potential disease progression. Although it is recognized that tumor-induced lymphangiogenesis facilitates metastasis into LNs in murine models, tumor-induced alterations in human lymphatic vessels remain obscure. Here we use single-cell RNA sequencing and high-resolution spatial transcriptomics to profile lymphatic endothelial cell (LEC) subsets in paired metastatic and non-metastatic LNs obtained from female patients with treatment-naïve breast cancer. Tumor metastasis decreases immunoregulatory LEC subsets, such as PD-L1&lt;sup>+&lt;/sup> subcapsular sinus LECs, while inducing an increase in capillary-like CD200&lt;sup>+&lt;/sup> HEY1&lt;sup>+&lt;/sup> LECs. Matrix Gla protein (MGP) is the most upregulated gene in metastatic LN L</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T16:36:01.922Z</modification><creation>2026-05-18T03:13:17.698Z</creation></dates><accession>S-EPMC12623973</accession><cross_references><pubmed>41249124</pubmed><doi>10.1038/s41467-025-64981-z</doi></cross_references></HashMap>